Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201201124 Principal Investigator: Wang-Gillam, Andrea
Title: Phase IB Study of FOLFIRINOX and PF-04136309 in Patients with Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Description: The purpose of this research study is to find the best dose of the study drug (PF-04136309) in combination with FOLFIRINOX as well as to see what the side effects of this treatment regimen are. PF-04136309 is considered investigational, which means that it has not been approved by the U.S. Food and ...MORE
___________________________________________________________________________________________________
 Number: 201404048 Principal Investigator: Wang-Gillam, Andrea
Title: A Multicenter Phase II Study of NPC-1C in Combination with Gemcitabine and nab-Paclitaxel versus Gemcitabine and nab-Paclitaxel alone in Patients with Metastatic or Locally Advanced Pancreatic Cancer Previously Treated with FOLFIRINOX
Description: The purpose of this study is to find out if giving NPC-1C (an investigational drug) with standard chemotherapy helps control pancreatic cancer better than standard chemotherapy alone....MORE
___________________________________________________________________________________________________
 Number: 201401025 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 2B, Randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 Compared to Chemotherapy or to CRS-207 Alone in Adults with Previously-Treated Metastatic Pancreatic Adenocarcinoma
Description: The purpose of this research study is to test whether GVAX pancreas vaccine and CRS-207 together are safe and work better than chemotherapy to treat patients with advanced pancreatic cancer who have received at least one prior chemotherapy treatment for cancer that has spread beyond the pancreas....MORE
___________________________________________________________________________________________________
 Number: 201311061 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 1b/2 Study of OMP-59R5 in Combination with Nab-Paclitaxel and Gemcitabine in Subjects with Previously Untreated Stage IV Pancreatic Cancer
Description: The purpose of this study is to test if OMP-59R5 is able to delay tumor growth, or increase how long people with metastatic pancreatic cancer live, or shrink tumors in subjects with stage IV pancreatic cancer who have not been treated....MORE
___________________________________________________________________________________________________
 Number: 201310160 Principal Investigator: Wang-Gillam, Andrea
Title: An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination with Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects with Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Description: The purpose of this research study is to investigate the safety of the study drug TH-302 in combination with two other chemotherapy drugs in patients with advanced pancreatic cancer who have not been treated before, and to find out the best dose to further test the study drug....MORE
___________________________________________________________________________________________________
 Number: 201304099 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic Cancer
Description: There are two parts to this study. The purpose of both parts is to evaluate PEGPH20 at a dose of 3.0 µg/kg in combination with 2 chemotherapy drugs (a standard dose of gemcitabine plus a dose of nab-paclitaxel that has been tested in pancreatic cancer patients) versus gemcitabine and nab-paclitaxel ...MORE
___________________________________________________________________________________________________
 Number: 201109243 Principal Investigator: Linehan, David
Title: 30-day readmission following pancreatectomy: a root-cause analysis
___________________________________________________________________________________________________
 Number: 201103202 Principal Investigator: Wang-Gillam, Andrea
Title: Construction of Pancreatic Cancer Tissue and Stroma Array
___________________________________________________________________________________________________